June 2022

A clinical trial shows positive results for the most common cutaneous lymphoma treatment with an immunosuppressive drug

Dr. Cristina Muniesa and Dr. Octavi Servitje, from the Dermatology Service of the Bellvitge University Hospital (HUB) and IDIBELL researchers, participated in this study that evaluates the use of topical pimecrolimus in mycosis fungoides and was published in the prestigious journal The Lancet Haematology.

A clinical trial shows positive results for the most common cutaneous lymphoma treatment with an immunosuppressive drug Read More »

Discovered epigenetic alterations associated with the COVID-19 related severe inflammatory syndrome in childhood

Dr. Aurora Pujol from IDIBELL and Dr. Manel Estaller from the Josep Carreras Leukaemia Research Institute identified an epigenetic signature associated to the development of the Multisystem Inflammatory Syndrome in Children (MIS-C) after a SARS-CoV-2 virus infection.

Discovered epigenetic alterations associated with the COVID-19 related severe inflammatory syndrome in childhood Read More »

A study describes a new way to generate insulin-producing cells

Researchers from the Karolinska Institute in Sweden, in collaboration with Meritxell Rovira from IDIBELL, the P-CMRC, and the UB show that a recently identified molecule stimulates the formation of new insulin-producing cells in zebrafish and in mammalian tissues.

A study describes a new way to generate insulin-producing cells Read More »

A neuroscientific study in the Sónar+D shows that we remember better and are predisposed to pay more for songs that arouse our curiosity

Through a live experiment, researchers assessed the curiosity aroused by a new song and its impact on audience memory and decision-making.

A neuroscientific study in the Sónar+D shows that we remember better and are predisposed to pay more for songs that arouse our curiosity Read More »

The second round of STARS escape room implementations has been a success

One and a half year after its debut, the STARS Game project has just reached its midpoint, Thus, the four partners have already delivered two rounds of workshops and implementations. Everyone’s experience regarding the escape room ended up being very positive and rewarding.

The second round of STARS escape room implementations has been a success Read More »

Ernest Nadal presents at ASCO the benefits of treating patients with lung cancer and brain metastases with chemo-immunotherapy

A group from IDIBELL, Catalan Institute of Oncology, and the Spanish Lung Cancer Group (GECP) have shown that the combination of atezolizumab with carboplatin and pemetrexed is safe and effective as a first treatment option in a group of 40 patients.

Ernest Nadal presents at ASCO the benefits of treating patients with lung cancer and brain metastases with chemo-immunotherapy Read More »

Large-scale genotyping identifies the molecular cause of two cases of familial globozoospermia

A genome-wide association study in a family with two males with infertility due to globozoospermia allows the identification of the first case of compound heterozygosis for two different mutations in the DPY19L2 gene.

Large-scale genotyping identifies the molecular cause of two cases of familial globozoospermia Read More »

A new international guideline helps advance in diagnosis and treatment of progressive pulmonary fibrosis

A new international consensus guideline based on scientific evidence represents an improvement in the diagnosis and treatment of patients with certain fibrosing lung diseases.

A new international guideline helps advance in diagnosis and treatment of progressive pulmonary fibrosis Read More »

Scroll to Top